Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Tratamiento con opiáceos para el dolor de la artritis reumatoide

Información

DOI:
https://doi.org/10.1002/14651858.CD003113.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 09 noviembre 2011see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Salud musculoesquelética

Copyright:
  1. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Samuel L Whittle

    Correspondencia a: Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, Australia

    [email protected]

    [email protected]

  • Bethan L Richards

    Rheumatology, Royal Prince Alfred Hospital, Camperdown, Australia

  • Elaine Husni

    Department of Rheumatic and Immunologic Diseases, Cleveland Clinic: Orthopedic and Rheumatologic Institute, Cleveland, USA

  • Rachelle Buchbinder

    Monash Department of Clinical Epidemiology at Cabrini Hospital, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Malvern, Australia

Contributions of authors

SW wrote the current version of the protocol and wrote the review.

EH wrote the original version of the protocol, which provided a base for the development of the current version.

RB, BR and EH provided comments and suggestions on draft versions of the protocol and review and all authors approved the current version.

Sources of support

Internal sources

  • Cabrini Hospital, Australia.

    In kind support

  • Monash University, Australia.

    In kind support

  • The Queen Elizabeth Hospital, Australia.

    In kind support

  • Royal Prince Alfred Hospital, Australia.

    In kind support

External sources

  • No sources of support supplied

Declarations of interest

None known

Acknowledgements

The authors thank Louise Falzon, Trials Search Coordinator of the Cochrane Musculoskeletal Group, for assisting with the design of the search strategy.

Version history

Published

Title

Stage

Authors

Version

2011 Nov 09

Opioid therapy for treating rheumatoid arthritis pain

Review

Samuel L Whittle, Bethan L Richards, Elaine Husni, Rachelle Buchbinder

https://doi.org/10.1002/14651858.CD003113.pub3

2010 Dec 08

Opioid therapy for treating rheumatoid arthritis pain

Protocol

Samuel L Whittle, Bethan L Richards, Elaine Husni, Rachelle Buchbinder

https://doi.org/10.1002/14651858.CD003113.pub2

2001 Apr 23

Opioid therapy for treating rheumatoid arthritis pain

Protocol

Elaine Husni, Vivian Welch, Lee Simon, Beverley Shea, George A Wells, Joan Peterson, Jessie L McGowan, Peter Tugwell

https://doi.org/10.1002/14651858.CD003113

Differences between protocol and review

The protocol specified that short and long‐term outcomes for the following outcomes would be included in the summary of findings table: proportion reporting pain relief of 30% or greater, total number of withdrawals due to adverse effects, number of serious adverse events, function and quality of life. As none of the included studies reported data for quality of life or the proportion reporting pain relief of 30% or greater, these outcomes were not included in the summary of findings table. Three additional outcomes (the proportion of patients reporting PGIC of 'good' or 'very good', the number of withdrawals due to inadequate analgesia, and the number of participants reporting adverse events) were reported in several of the included studies and were felt to be of importance to patients. These outcomes have been added to the summary of findings table. No outcomes were measured beyond six weeks, so only short‐term outcomes were included in the table.